Psychemedics Statistics Share Statistics Psychemedics has 5.89M
shares outstanding. The number of shares has increased by 1.21%
in one year.
Shares Outstanding 5.89M Shares Change (YoY) 1.21% Shares Change (QoQ) 0% Owned by Institutions (%) 0.34% Shares Floating 4.31M Failed to Deliver (FTD) Shares 5,569 FTD / Avg. Volume 17.94%
Short Selling Information The latest short interest is 38.6K, so 0.65% of the outstanding
shares have been sold short.
Short Interest 38.6K Short % of Shares Out 0.65% Short % of Float 0.87% Short Ratio (days to cover) 1.92
Valuation Ratios The PE ratio is -7.06 and the forward
PE ratio is null.
Psychemedics's PEG ratio is
0.13.
PE Ratio -7.06 Forward PE n/a PS Ratio 0.67 Forward PS n/a PB Ratio 2.56 P/FCF Ratio 15.61 PEG Ratio 0.13
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Psychemedics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.82,
with a Debt / Equity ratio of 0.23.
Current Ratio 1.82 Quick Ratio 1.82 Debt / Equity 0.23 Debt / EBITDA 6.1 Debt / FCF 1.38 Interest Coverage -72.81
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $169.7K Profits Per Employee $-16.04K Employee Count 116 Asset Turnover 2.37 Inventory Turnover n/a
Taxes Income Tax -55K Effective Tax Rate 2.87%
Stock Price Statistics The stock price has increased by 45.9% in the
last 52 weeks. The beta is 0.67, so Psychemedics's
price volatility has been higher than the market average.
Beta 0.67 52-Week Price Change 45.9% 50-Day Moving Average 2.14 200-Day Moving Average 2.25 Relative Strength Index (RSI) 54.16 Average Volume (20 Days) 31,048
Income Statement In the last 12 months, Psychemedics had revenue of 19.68M
and earned -1.86M
in profits. Earnings per share was -0.32.
Revenue 19.68M Gross Profit 7.1M Operating Income -1.89M Net Income -1.86M EBITDA 191K EBIT -1.89M Earnings Per Share (EPS) -0.32
Full Income Statement Balance Sheet The company has 1.42M in cash and 1.17M in
debt, giving a net cash position of 251K.
Cash & Cash Equivalents 1.42M Total Debt 1.17M Net Cash 251K Retained Earnings -18.63M Total Assets 8.32M Working Capital 2.23M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 929K
and capital expenditures -87K, giving a free cash flow of 842K.
Operating Cash Flow 929K Capital Expenditures -87K Free Cash Flow 842K FCF Per Share 0.14
Full Cash Flow Statement Margins Gross margin is 36.07%, with operating and profit margins of -9.62% and -9.45%.
Gross Margin 36.07% Operating Margin -9.62% Pretax Margin -9.73% Profit Margin -9.45% EBITDA Margin 0.97% EBIT Margin -9.62% FCF Margin 4.28%
Dividends & Yields PMD pays an annual dividend of $0.35,
which amounts to a dividend yield of 5.68%.
Dividend Per Share $0.35 Dividend Yield 5.68% Dividend Growth (YoY) 0% Payout Ratio -68.63% Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for PMD.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Aug 1, 2002. It was a
backward
split with a ratio of 1:4.
Last Split Date Aug 1, 2002 Split Type backward Split Ratio 1:4
Scores Altman Z-Score 1.76 Piotroski F-Score 4
